# PolyPeptide Laboratories (Sweden) AB – FDA Inspection, Oct 7, 2009

Source: https://www.keypedia.com/records/fda_inspections/polypeptide-laboratories-sweden-ab/37839365-6b25-4ffe-920a-cfe25fed95be
Source feed: FDA_Inspections

> FDA inspection 618582 of PolyPeptide Laboratories (Sweden) AB, October 07, 2009. Classification: No Action Indicated (NAI). 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 618582
- Company Name: PolyPeptide Laboratories (Sweden) AB
- Inspection Date: 2009-10-07
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1273228 - 2025-01-23
- [FDA Inspection 1096761 - 2019-04-10](https://www.keypedia.com/records/fda_inspections/polypeptide-laboratories-sweden-ab/eeab8d89-54c5-40a9-94fa-6da2ed2e6810)
- FDA Inspection 976058 - 2016-05-27
- [FDA Inspection 854145 - 2013-09-20](https://www.keypedia.com/records/fda_inspections/polypeptide-laboratories-sweden-ab/1cf123af-6ee6-4a54-9c8c-9205d964b437)

Company: https://www.keypedia.com/companies/polypeptide-laboratories-sweden-ab/19a9ab2c-a6ae-4e91-b047-429b116721a6

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c